ClinicalTrials.gg
RecruitingNCT06003686Updated Sep 30, 2026

Spinal Cord Injury Model Systems (SCIMS) - Education Module

An interventional study of PVA Consumer Guide and WebMD in Spinal Cord Injuries, Obesity and Cardiometabolic Syndrome, sponsored by University of Miami. Recruiting at 3 sites in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by University of Miami · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.
Updated Sep 30, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 45 studies in Spinal Cord Injuries by University of Miami — 12 open to participants now, 14 under way, 1 of them phase 3. Spinal Cord Injuries · University of Miami.

Planned enrollment
Largest of 37
250 · median 26
Started
2024
with 5 others
No phase
33 of 45
10 open now
Primary completion
2026-12
later than 0 of 13 live
Registered
34th of 45
by date

Among the 45 studies in Spinal Cord Injuries by University of Miami, this one has the largest planned enrollment of the 37 interventional ones that give a count, is one of 6 that started in 2024, is one of 33 with no phase, reaches primary completion later than 0 of the 13 other live ones, and was the 34th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

12 of the 45 studies in Spinal Cord Injuries by University of Miami are open now, in 1 country. Recruiting first, the newest first:

6 more — sign in →

By country, each count listing its studies:

All 12 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 45 studies in Spinal Cord Injuries by University of Miami, or all of them as a file.
02

Study summary

The purpose of this study is to find out if receiving education regarding increased risks of cardiometabolic disease helps subjects understand these risks and how these risks participants' health.

03

Conditions studied

  • Spinal Cord Injuries
  • Obesity
  • Cardiometabolic Syndrome
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Men and Women with SCI/D aged 18-70 years.
  2. Neurologically complete and incomplete American Spinal Injury Association (ASIA) Impairment scale (AIS) A-D spinal cord levels C5 and below.
  3. Enrolled no later than 4 months following discharge from initial rehabilitation from SCI.

Exclusion criteria

Exclusion Criteria:

  1. Pregnancy determined by urine testing in sexually active females.
  2. Cognitive impairment that compromises the legitimacy of consent.
  3. Grade 3-4 pressure injury at the time of study entry.
  4. Prisoners
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    Paralyzed Veterans of America (PVA) Cardio-Metabolic Disease (CMD) Consumer Guide Group

    Hard paper copy of as well as an electronic copy of the guide will be provided to subjects and study staff will provide a general review of the contents of the guide with subjects during their education sessions. Participants will be in this group for 6 months.

    Behavioral: PVA Consumer Guide

  • Active comparator
    WebMD Group

    Subjects will be introduced to WebMD and its contents. A brief document will be provided that includes site summary and website. Study staff will provide a very brief overview of the site. Participants will be in this group for 6 months.

    Behavioral: WebMD

Interventions

  • BehavioralPVA Consumer Guide

    Subject's will receive education on the PVA consumer guide 3 times over the course of the study. Each session will be approximately 10-15 minutes and will consist of a general review of the nutrition, exercise, and general healthy living guidelines content included.

  • BehavioralWebMD

    Subject's will receive education on how to navigate the WebMD site and find information on health, exercise and nutrition 3 times over the course of the study. Each session will be approximately 10-15 minutes and will consist of a general review of the health and wellness content available on the website. At study completion, subjects in this group will be provided with the PVA guide and a brief orientation of the nutrition, exercise, and general healthy living guidelines content included in the guide.

06

What researchers measure

Primary outcomes

  1. Change in Effectiveness of education modules as determined in the Knowledge Test

    Effectiveness as determined by the number of correct answers on the Knowledge Test where the higher number of correct answers indicates increased knowledge of the information provided.

    Time frame: baseline, up to 6 months

Secondary outcomes

  1. Change in Body Weight as determined by kilograms (kg)

    Body weight will be measured in kilograms

    Time frame: baseline, up to 6 months

  2. Change in Body composition as determined by Dual X-ray Absorptiometry (DXA)

    Body composition will be measured in grams using DXA

    Time frame: baseline, up to 6 months

  3. Change in Body composition as determined by Dual X-ray Absorptiometry (DXA) in Percentage

    Body composition will be expressed as a percentage of body fat (BF) using DXA

    Time frame: baseline, up to 6 months

  4. Change in sugar metabolism as determined by Insulin resistance (IR)

    Sugar metabolism will be determined as IR calculated using the formula (fasting serum glucose\*fasting serum insulin/22.5). Lower values indicate a higher degree of insulin sensitivity. Fasting values are obtained from blood samples

    Time frame: baseline, up to 6 months

  5. Change in Quality of Life (QoL) as measured by Quality Index Spinal Cord Injury Version III

    A composite score will be obtained to assess change in QoL using a six-point Likert scale. Scores for satisfaction section range from "1- very satisfied" to "6-very dissatisfied". On the important section scoring ranges from "1-very important" to "6- very unimportant"

    Time frame: baseline, up to 6 months

  6. Change in Quality of Life (QoL) Using the International Spinal Cord Injury Basic Data Set

    QoL values will be determined using a scale ranging from 0 (completely dissatisfied) to 10 (completely satisfied).

    Time frame: baseline, up to 6 months

  7. Change in heart disease risk as determined by cholesterol

    Risk of heart disease will be measured from a blood sample in mg/dL

    Time frame: baseline, up to 6 months.

  8. Change in heart disease risk as determined by blood pressure (BP)

    BP will be measured in mmHg using an arm cuff

    Time frame: baseline, up to 6 months.

07

Study locations

1 of 3 sites recruiting
  • MedStar National Rehabilitation Network
    Washington D.C., District of Columbia 20010, United States
    Active, not recruiting

    Not enrolling at this site.

  • University of Miami - Miami Project to Cure Paralysis
    Miami, Florida 33136, United States
    Active, not recruiting

    Not enrolling at this site.

  • Baylor Scott & White Institute for Research
    Dallas, Texas 75246, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Dec 2026, 33 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 33 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 30, 2026: primary completion Oct 2026 → Dec 2026 and completion Oct 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 16, 2023
First posted
Aug 22, 2023
StartActual
Mar 5, 2024
Primary completionEst.
Dec 31, 2026was Oct 2026
CompletionEst.
Dec 31, 2026was Oct 2026
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 31, 2026→Dec 31, 2026
Sep 30, 2026
Study completion
Oct 31, 2026→Dec 31, 2026
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Primary completion Oct 31, 2026→Dec 31, 2026
    Study completion Oct 31, 2026→Dec 31, 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06003686
Collaborators
National Institute on Disability, Independent Living, and Rehabilitation Research
Responsible party
Gary Farkas (Principal Investigator, University of Miami) — Principal investigator
First posted
Aug 22, 2023
Start date
Mar 5, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 30, 2026

Study contacts

Patricia Graham, MS
Contact
pgraham1@med.miami.edu
3052435119
Gary Farkas, PhD
principal investigator · University of Miami

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion